Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
35M
-
Number of holders
-
151
-
Total 13F shares, excl. options
-
26.6M
-
Shares change
-
-1.01M
-
Total reported value, excl. options
-
$1.68B
-
Value change
-
-$53.2M
-
Put/Call ratio
-
0.64
-
Number of buys
-
79
-
Number of sells
-
-59
-
Price
-
$63.40
Significant Holders of Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) as of Q4 2024
173 filings reported holding IRON - Disc Medicine, Inc. - Common Stock, $0.0001 par value per share as of Q4 2024.
Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) has 151 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.6M shares
of 35M outstanding shares and own 75.97% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (2.51M shares), FMR LLC (1.87M shares), BlackRock, Inc. (1.86M shares), ORBIMED ADVISORS LLC (1.79M shares), Frazier Life Sciences Management, L.P. (1.75M shares), Paradigm Biocapital Advisors LP (1.5M shares), WELLINGTON MANAGEMENT GROUP LLP (1.4M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.39M shares), JANUS HENDERSON GROUP PLC (1.22M shares), and VANGUARD GROUP INC (1.07M shares).
This table shows the top 151 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.